Depression Flashcards
DSM5 Diagnostic Criteria :
1. Must have how many of the following on MOST DAYS within 2 weeks ?
- D
- A
- Substantial ___
5.I or H - F or L
- Poor ___ or ability to think or __
- Feelings of ____ or ___
- P or R (observed)
- Recurrent thoughts of ___
- out of the 5 required, 1 of 2 of the following must be included?
- 5
- Depressed or irritable mood nearly all day occurring most days
- anhedonia or loss of interest
- weight loss or gain (>=5% of body weight)
- Insomnia, hypersomnia
- fatigue or low energy
- concentration , indecisiveness
- worthlessness, inappropriate guilt
- psychomotor agitation , retardation
- death or suicide with or without plan
- Anhedonia or depressed mood
What are some risk factors ?
1. E
2. Gender ?
3. History ? (2)
4. Comorbidities ? (2)
5. Meds/substances : (5)
6. Diet?
7. lack of ?
8. ___ events
- Environmental : loss of spouse, loved one, dysfunctional childhood, divorce/stressful events
- Female, postpartum
- Prev episode or suicide attempt, family hx
- Medical and SUD
- Barbiturates, Bdz’s, alcohol, cannabinoids, opiates
- Imbalance of omega 6 fatty acid compared to omega 3 fatty acid may incr risk
- Social support
- Psychosocial
Secondary Causes of Depressive Sx’s :
Note, these must be ruled out before you can make a diagnosis
- Medical causes (5 main ones)
- Medication causes (6)
- Hypothyroidism , MS, CAD/CVA/MI/CHF, Fibromyalgia/Pain disorder, Vit D deficiency
-DM, Parkinson’s, Alz, Cancer, HIV/AIDS , RA
- BZD’s, IFNAlpha/PegIFN, Isotretinoin, Opiates, Tramadol, naltrexone
Duration of Treatment :
1. during acute phase, when can u see improvement? full benefit?
2. Continuation phase is ?
3. maintenance phase is?
4. Whats required for all pts ?
- 1-2 weeks, 4-12 weeks
- 4-9 months at acute phase dose
- lifetime tx for high risk
- acute and continuation phase
SSRI’s :
1. Name 7
2. For the following AE’s, state which drug they’re worst with and which one is common :
A. CNS (Sedation, insomnia, HA/Vivid dreams/nightmares)
B. GI effects (2)
C. Anticholinergic Effects (1)
D. Bleeding/Anemia
- Which AE occurs in 30-73% of pt’s?
- Worst with which drugs? (2)
- Which can cause withdrawal syndrome? (2)
- Miscellaneous Ae’s ? (8)
- What’s a BBW for SSRI’s?
-because of this BBW, what do u need to do?
- Fluoxetine, Sertraline, Paroxetine, Fluvoxamine, Citalopram, Escitalopram, Vilazodone
- Sedation : worst with fluvox, paroxetine
Insomnia : worst with fluoxetine
Ha/Vivid dreams/nightmares =common
B. N/V/D constipation : worst with sertraline, paroxetine
C. Worst with paroxetine (Dry mouth, constipation)
D. All drugs have potential, due to platelet serotonin depletion
- Sexual dysfunction
- Fluoxetine and paroxetine (Delayed ejac, anorgasmia, impaired libido)
- Fluvox and paroxetine
- Sweating, SIADH, Weight gain, Bruxism, Decr BMD, extrapyrimadal sx’s, QT prolong, suicidal ideation
- 18-24 yrs, incr suicidal thinking/behavior during first 2 months of treatment
- Need to taper all antidepressants rather than abrupt DC
Which drug has Qt prolongation ?
Max daily dose?
Max daily dose for patients w/hepatic impairment, > 60, or who are CYP2c19 PM, or concomitant cimetidine?
Use caution in patients with ?
Avoid in patients with ?
Before starting Citalopram, what needs to be corrected?
Incr ___ in pt’s with CHF or heart problems
ALL antidepressants have what risk?
CITALOPRAM
40mg/day
20mg/day
CHF, bradyarrhythmias, predisposition to hypokalemia or hypomagnesemia
congenital long QT syndrome
Hypokal and Hypomag
ECG monitoring
Suicide risk
SNRI :
1. Name 4
2. Common AE”s for the class? (7)
3. Venlafaxine Ae’s specifically? (2)
4. Duloxetine? (2)
5. Levomilnacipran? (5)
6. Which drug associated w/incr risk for death vs SSRI in the case of overdose?
7. What to do in elderly population or those with anxiety disorders?
- Venlafaxine , Duloxetine, Desvenlafaxine, Levomilnacipran
- GI effects (nausea, constipation, diarrhea), insomnia/somnolence, sexual dysfunction, dizziness, dry mouth, sweating, suicide risk
- HTN (dose related), Withdrawal
- Hepatitis, and cholestatic jaundice
- HTN, tachycardia, mydriasis, urinary retention, seizures
- Venlafaxine (usually in combo w/ETOH and drugs), but less risk than TCA’s
- Start low and go slow!
Atypical Antidepressants :
1. Serotonin receptor antags such as? (3)
2. Name 3 others
- trazodone is usually used as ? which formulation approved for depression?
- what’s last line of these agents for depression and why?
- Phenylpiprazines : AE’s? (5)
- Mirtazapine : Indications? (2)
- AE’s? (2) but has no____ (2)
- Bupropion : FDA indications (2)
- IR , SR, ER dosing frequency
- Bupropion AE’s? (6)
- CI in which population ? (2)
- CYP interactions for wellbutrin?
- Can incr levels of? (4)
1.Phenylpiprazines : Nefazodone, Trazodone,
-Mirtazapine
- Bupropion, Vortioxetine, Dextromethorphan-Bupropion
- Sedative-hypnotic , Trazodone XR
- Nefazodone , Hepatotoxic
- Sedation/dizzy, confusion, Orthostasis, Priapism (Traz mainly), Anxiety and panic attacks
- depression (FDA) and nausea
- sedation (low doses), weight gain .
-Nausea or sexual dysfunction - Depression, smoking cessation
- q6hrs, q8hrs, q24hrs
- Insomnia, Agitation , weight loss, incr BP, HA, seizures
- Seizure disorders, ED’s
- CYP2D6 inhibitor
- venlafax, desipramine, dextromethorph, vortiox
Vortioxetine (Trintellix) :
1. Indications?
2. Ae’s? (3) .. May have less what ?
3. Dosing. ?
4. will have decr levels due to cyp inducers such as ? (2)
- MDD, May be helpful in ADHD sx’s
- N/V/Constipation , may have LESS sexual dysfunction than ssri’s and snri’s
- titration from 10mg to 20 mg daily
- Carbamazepine and Phenytoin
TCA’s
1. Name some tertiary (4) vs secondary (3)
2. Neuro ae’s? (6)
3. GI/GU ae’s?
4. CV ae’s? (5)
5. Other ae’s such as ?
6. Which have greater ae’s?
7. In elderly, should do what and avoid ?
8. NOT preferable in which pt’s?
- Tertiary : Amitriptyline, Doxepin, Imipramine, Clomipramine
Secondary : Protriptyline, desipramine, nortriptyline - Sedation , mental status changes, respiratory depression, lethargy, confusion, lower seizure threshold
- Constipation, weight GAIN, dry mouth, urinary retention
- Orthostasis, tachycardia, incr qtc, TdP, Vtach
- Sexual dysfunction, switch to mania
- Tertiary TCA’s
- decr dose, avoid tertiary
- pt’s with suicidal ideation or past suicide attempts
MAOI’s : Phenelzine and Selegiline EMSAM
1. AE’s?
-CNS (3)
-CV (3)
-Endocrine
-GI/GU
2. EMSAM specific adrs?
- Sedation/insomnia , HA, switch to mania
- Ortho hypo, decr HR, hypertensive crises
- Anorgasmia/Sexual impotence , SIADH
- Dry mouth, constipation, urinary hesitancy, weight GAIN
- HA, insomnia, application site rxns
Do not use MAOI’s within 5 weeks of discontinueing ___ or 2 weeks of discontinuing other ____,_____,___ or 3 weeks of discontinuing ___
How long must u wait after DC of MAOI to swich to another antidepressant ?
EMSAM only is CI with which 2 drugs?
Fluoxetine, SSRI, TCA, MAOI, Vortioxetine
2 weeks
Carbam, Oxcarbam
Guidelines :
1. Therapeutic trial should be how long?
2. If no response to monotherapy, what should u do?
3. If partial response to monotherapy at optimized dose, what should you do?
- 4 to 6 weeks of optimized/therapeutic dose
- Switch within or between pharmacological classes
- augmentation with psychotherapy and augmentation with NON-MAOI or NON-Antidepressant medication
Discontinuation of Therapy :
How long should patients be treated before considering a taper?
All ___ should be gradually titrated down and discontinued over ___
Warn pt’s about sx’s of __ espeically with (4) ?
When should we consider long term therapy?
- 4-9 months or about 7 months
- SSRI’s. several days
- withdrawal. venlafaxine, paroxetine, levomilnacipran, desvenlafaxine
- those with recurrent episodes, first episode after 60 yrs of age
Serotonin withdrawal syndrome :
1) due to ?
2) especially for meds? (7)
3) Sx’s?
4) onset?
5) Duration ?
- Abrupt discontinuation of meds
- short half life like doxepin, amitriptyline, imipramine, desipramine, parox, fluvox, venlafax
- flu like sx’s, dizzy, insomnia, nausea, shooting pains in extremeities, anxiety, lethargy
- 48 hrs after last dose
- 3 days to 2 weeks but can be longer